Patient Knowledge on Reporting Adverse Drug Reactions in Poland

Overview

Journal Patient Prefer Adherence

Date 2017 Jan 19

PMID 28096661

Citations 4

Authors

Anna Staniszewska

Marta Dabrowska-Bender

Dominik Olejniczak

Aneta Duda-Zalewska

Magdalena Bujalska-Zadrozny

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of the study was to assess patient knowledge on reporting of adverse drug reactions.

Materials And Methods: A prospective study was conducted among 200 patients. The study was based on an original survey composed of 15 single- and multiple-choice questions. The study involved individuals who have experienced adverse reactions as well as individuals who have never experienced any adverse reactions; people over the age of 18; literate; residing in Mazowieckie Voivodeship, who have not been diagnosed with any disease that could compromise their logical thinking skills.

Results: The respondents who lived in the city had a greater knowledge compared to the respondents who lived in the countryside (Pearson's =47.70, =0.0013). The respondents who lived in the city were also more statistically likely to provide a correct answer to the question about the type of adverse reactions to be reported (Pearson's =50.66, =0.012). Statistically significant associations were found between the place of residence of the respondents and the correct answer to the question about the data that must be included in the report on adverse reactions (Pearson's =11.7, <0.0001).

Citing Articles

Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study.

Alkofide H, Almalag H, Alromaih M, Alotaibi L, Altuwaijri N, Al Aloola N Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931351 PMC: 11206558. DOI: 10.3390/ph17060683.

Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study.

Valinciute A, Gerbutaviciene R, Paukstaitiene R, Kubiliene L Healthcare (Basel). 2023; 11(8).

PMID: 37107967 PMC: 10138446. DOI: 10.3390/healthcare11081133.

Parental reporting of adverse drug reactions in South Africa: An online survey.

Pillay S, Mulubwa M, Viljoen M Afr J Prim Health Care Fam Med. 2021; 13(1):e1-e8.

PMID: 34636609 PMC: 8517735. DOI: 10.4102/phcfm.v13i1.2880.

Adverse Drug Reactions in Norway: A Systematic Review.

Vaismoradi M, Logan P, Jordan S, Sletvold H Pharmacy (Basel). 2019; 7(3).

PMID: 31349705 PMC: 6789571. DOI: 10.3390/pharmacy7030102.

References

Vlahakes G . The value of phase 4 clinical testing. N Engl J Med. 2006; 354(4):413-5. DOI: 10.1056/NEJMe058272. View

Ivy S, Siu L, Garrett-Mayer E, Rubinstein L . Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res. 2010; 16(6):1726-36. PMC: 5207802. DOI: 10.1158/1078-0432.CCR-09-1961. View

Schetz D, Sein Anand J . [Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region]. Przegl Lek. 2016; 72(9):475-8. View

de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K . Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008; 31(6):515-24. DOI: 10.2165/00002018-200831060-00006. View

Toklu H, Uysal M . The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008; 30(5):556-62. DOI: 10.1007/s11096-008-9209-4. View

Suyagh M, Farah D, Farha R . Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015; 23(2):147-53. PMC: 4421001. DOI: 10.1016/j.jsps.2014.07.001. View

Green C, Mottram D, Rowe P, Pirmohamed M . Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001; 51(1):81-6. PMC: 2014418. DOI: 10.1046/j.1365-2125.2001.01306.x. View

Herdeiro M, Figueiras A, Polonia J, Gestal-Otero J . Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal. Drug Saf. 2006; 29(4):331-40. DOI: 10.2165/00002018-200629040-00004. View

Generali J, Danish M, Rosenbaum S . Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995; 29(4):365-9. DOI: 10.1177/106002809502900404. View

10.

Sweis D, Wong I . A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000; 23(2):165-72. DOI: 10.2165/00002018-200023020-00006. View

11.

Granas A, Buajordet M, Stenberg-Nilsen H, Harg P, Horn A . Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2006; 16(4):429-34. DOI: 10.1002/pds.1298. View

12.

Aagaard L, Nielsen L, Hansen E . Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf. 2009; 32(11):1067-74. DOI: 10.2165/11316680-000000000-00000. View

13.

Abdel-Latif M, Abdel-Wahab B . Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015; 23(2):154-61. PMC: 4420988. DOI: 10.1016/j.jsps.2014.07.005. View